Department of Internal Medicine, Kyung Hee University Hospital at Gang Dong, College of Medicine, Kyung Hee University, Seoul, Korea.
Korean J Gastroenterol. 2024 Oct 25;84(4):177-187. doi: 10.4166/kjg.2024.094.
BACKGROUND/AIMS: The use of 1-L polyethylene glycol with ascorbate (PEG/Asc) and oral sulfate tablets (OST) as low-volume bowel preparation agents has gradually increased. However, these agents may induce acute gastropathy during bowel preparation, particularly in elderly populations. This study aimed to compare the incidence of acute gastropathy of 1-L PEG/Asc and OST according to age, as well as efficacy and safety.
This retrospective study included patients who underwent esophagogastroduodenoscopy (EGD) and colonoscopy for screening on the same day and underwent bowel preparation using OST or 1-L PEG/Asc. We collected EGD findings related to acute gastropathy, bowel-cleansing score using the Boston Bowel Preparation Scale (BBPS), polyp or adenoma detection rate (ADR), and laboratory parameters.
Of 4,711 patients, 1,758, 2,241, and 712 were in the younger (18-49 years), middle-aged (50-64 years), and older (≥65 years) groups, respectively. In all age groups, the OST group had higher rates of acute gastropathy than the 1-L PEG/Asc group. The younger-, middle-, and older-aged groups had OST and 1-L PEG/Asc usage rates of 42.9% and 11.6%, 41.2% and 16.0%, and 41.5% and 16.4%, respectively. Notably, in the younger group, the total BBPS and ADR scores were significantly higher in the OST group than in the 1-L PEG/Asc group; however, these did not differ in the other age groups.
Acute gastropathy was more strongly associated with OST than with 1-L PEG/Asc in all age groups. Therefore, physicians should consider acute gastropathy associated with low-volume agents in all age groups when performing bowel preparation.
背景/目的:聚乙二醇与抗坏血酸钠(PEG/Asc)和口服硫酸盐片剂(OST)作为低容量肠道准备剂的使用逐渐增加。然而,这些药物在肠道准备期间可能会引起急性胃病,尤其是在老年人群中。本研究旨在根据年龄比较 1-L PEG/Asc 和 OST 引起急性胃病的发生率,并比较其疗效和安全性。
本回顾性研究纳入了同一天行内镜检查(EGD)和结肠镜检查并接受 OST 或 1-L PEG/Asc 肠道准备的患者。我们收集了与急性胃病相关的 EGD 结果、波士顿肠道准备量表(BBPS)的肠道清洁评分、息肉或腺瘤检出率(ADR)和实验室参数。
在 4711 名患者中,1758 名、2241 名和 712 名分别为年轻(18-49 岁)、中年(50-64 岁)和老年(≥65 岁)组。在所有年龄组中,OST 组的急性胃病发生率均高于 1-L PEG/Asc 组。年轻、中年和老年组的 OST 和 1-L PEG/Asc 使用率分别为 42.9%和 11.6%、41.2%和 16.0%以及 41.5%和 16.4%。值得注意的是,在年轻组中,OST 组的总 BBPS 和 ADR 评分明显高于 1-L PEG/Asc 组;然而,在其他年龄组中则没有差异。
在所有年龄组中,急性胃病与 OST 的相关性均强于与 1-L PEG/Asc 的相关性。因此,在进行肠道准备时,医生应考虑所有年龄组的低容量药物引起的急性胃病。